SCHEMBL16339494

SCHEMBL16339494

COc1cc2c(cc1OC)NC(=O)CC2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.57
CYP11B2 P19099 3/20 0.57
CYP19A1 P11511 2/20 0.57
CA9 Q16790 1/20 0.47
CYP1A2 P05177 2/20 0.47
NR3C1 P04150 1/20 0.46
PGR P06401 1/20 0.46
SLC6A4 P31645 1/20 0.46
KCNH2 Q12809 1/20 0.46
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
ALDH1A1 P00352 1/20 0.46
SRC P12931 2/20 0.46
EGFR P00533 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
NPC1 O15118 1/20 0.44
MAPK13 O15264 1/20 0.44
MAPK12 P53778 1/20 0.44
MAPK11 Q15759 1/20 0.44
MAPK14 Q16539 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30340281 0.89 CYP19A1 (0.48) CYP11B1CYP11B2CYP19A1SRCEGFR
SCHEMBL7429093 0.89 CYP19A1 (0.48) CYP11B1CYP11B2CYP19A1SRCEGFR
SCHEMBL16339815 0.89 CYP11B1 (0.49) CYP11B1CYP11B2CYP19A1CA9CYP1A2
SCHEMBL3309794 0.86 CYP11B1 (0.55) CYP11B1CYP11B2CYP19A1CA9CYP1A2
SCHEMBL10572961 0.86 CYP11B1 (0.52) CYP11B1CYP11B2CYP19A1CA9CYP1A2
SCHEMBL28398373 0.86 CYP11B1 (0.52) CYP11B1CYP11B2CYP19A1CA9CYP1A2
SCHEMBL2203230 0.86 CA9 (0.50) CYP11B1CYP11B2CYP19A1CA9CYP1A2
SCHEMBL6073613 0.84 ALDH1A1 (0.47) CYP11B1CYP11B2CYP19A1CA9CYP1A2
SCHEMBL578508 0.83 SRC (0.57) PDE3BPDE3ASRCEGFRCYP3A4
SCHEMBL8359848 0.82 CYP11B1 (0.46) CYP11B1CYP11B2CYP19A1CA9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111587239-B Method for producing lactam compound and lactam compound produced by the method 基础科学研究院 2024-04-02 CN disclosed
US-11046661-B2 Method for producing lactam compound, and lactam compound produced thereby INSTITUTE FOR BASIC SCIENCE (KR) 2021-06-29 US disclosed
US-11046661-B2 Method for producing lactam compound, and lactam compound produced thereby INSTITUTE FOR BASIC SCIENCE (KR) 2021-06-29 US disclosed
US-20200331871-A1 METHOD FOR PRODUCING LACTAM COMPOUND, AND LACTAM COMPOUND PRODUCED THEREBY INSTITUTE FOR BASIC SCIENCE (KR) 2020-10-22 US disclosed
US-20200331871-A1 METHOD FOR PRODUCING LACTAM COMPOUND, AND LACTAM COMPOUND PRODUCED THEREBY INSTITUTE FOR BASIC SCIENCE (KR) 2020-10-22 US disclosed
CN-111587239-A Method for producing lactam compound and lactam compound produced by same 基础科学研究院 2020-08-25 CN disclosed
WO-2019135604-A1 METHOD FOR PRODUCING LACTAM COMPOUND, AND LACTAM COMPOUND PRODUCED THEREBY 기초과학연구원 2019-07-11 WO disclosed
CN-105658650-B imidazole compounds as modulators of follicle stimulating hormone receptors and uses thereof 默克专利有限公司 2019-01-08 CN disclosed
US-10138233-B2 Imidazole compounds as modulators of FSHR and uses thereof MERCK PATENT GMBH (DE) 2018-11-27 US disclosed
EP-3013823-B1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF MERCK PATENT GMBH (DE) 2017-11-01 EP disclosed
EP-3013823-B1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF MERCK PATENT GMBH (DE) 2017-11-01 EP disclosed
US-9725465-B2 Biaryl acetamide compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2017-08-08 US disclosed
US-20160152609-A1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF MERCK PATENT GMBH (DE) 2016-06-02 US disclosed
US-20160152609-A1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF MERCK PATENT GMBH (DE) 2016-06-02 US disclosed
US-20160152609-A1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF MERCK PATENT GMBH (DE) 2016-06-02 US disclosed
EP-3013823-A1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF Merck Patent GmbH (DE) 2016-05-04 EP disclosed
US-20150065468-A1 BIARYL ACETAMIDE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORP (US) 2015-03-05 US disclosed
WO-2014209978-A1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF MERCK PATENT GMBH (DE) 2014-12-31 WO disclosed
WO-2014209978-A1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF MERCK PATENT GMBH (DE) 2014-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331871-A1 METHOD FOR PRODUCING LACTAM COMPOUND, AND LACTAM COMPOUND PRODUCED THEREBY SQLE, COASY, DHPS CYP11B1 1018/4885CYP11B2 809/4885CYP19A1 99/4885
US-20150065468-A1 BIARYL ACETAMIDE COMPOUNDS AND METHODS OF USE THEREOF ERBB2, ERBB3, AADAC CYP11B1 843/4885CYP11B2 580/4885CYP19A1 874/4885
US-10138233-B2 Imidazole compounds as modulators of FSHR and uses thereof FSHR, GNRHR, LHCGR CYP11B1 249/4885CYP11B2 305/4885CYP19A1 17/4885
US-11046661-B2 Method for producing lactam compound, and lactam compound produced thereby SQLE, COASY, DHPS CYP11B1 1018/4885CYP11B2 809/4885CYP19A1 99/4885
US-20160152609-A1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF FSHR, GNRHR, LHCGR CYP11B1 249/4885CYP11B2 305/4885CYP19A1 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.